TY - JOUR
T1 - IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
AU - Thompson, Leslie Michels
AU - Aiken, Charity T.
AU - Kaltenbach, Linda S.
AU - Agrawal, Namita
AU - Illes, Katalin
AU - Khoshnan, Ali
AU - Martinez-Vincente, Marta
AU - Arrasate, Montserrat
AU - O'Rourke, Jacqueline Gire
AU - Khashwji, Hasan
AU - Lukacsovich, Tamas
AU - Zhu, Ya-Zhen
AU - Lau, Alice L.
AU - Massey, Ashish
AU - Hayden, Michael R.
AU - Zeitlin, Scott O.
AU - Finkbeiner, Steven
AU - Green, Kim N.
AU - LaFerla, Frank M.
AU - Bates, Gillian
AU - Huang, Lan
AU - Patterson, Paul H.
AU - Lo, Donald C.
AU - Cuervo, Ana Maria
AU - Marsh, J. Lawrence
AU - Steffan, Joan S.
PY - 2009/12/28
Y1 - 2009/12/28
N2 - Expansion of the polyglutamine repeat within the protein Huntingtin (Htt) causes Huntington's disease, a neurodegenerative disease associated with aging and the accumulation of mutant Htt in diseased neurons. Understanding the mechanisms that influence Htt cellular degradation may target treatments designed to activate mutant Htt clearance pathways. We find that Htt is phosphorylated by the inflammatory kinase IKK, enhancing its normal clearance by the proteasome and lysosome. Phosphorylation of Htt regulates additional post-translational modifications, including Htt ubiquitination, SUMOylation, and acetylation, and increases Htt nuclear localization, cleavage, and clearance mediated by lysosomal-associated membrane protein 2A and Hsc70. We propose that IKK activates mutant Htt clearance until an age-related loss of proteasome/lysosome function promotes accumulation of toxic post-translationally modified mutant Htt. Thus, IKK activation may modulate mutant Htt neurotoxicity depending on the cell's ability to degrade the modified species.
AB - Expansion of the polyglutamine repeat within the protein Huntingtin (Htt) causes Huntington's disease, a neurodegenerative disease associated with aging and the accumulation of mutant Htt in diseased neurons. Understanding the mechanisms that influence Htt cellular degradation may target treatments designed to activate mutant Htt clearance pathways. We find that Htt is phosphorylated by the inflammatory kinase IKK, enhancing its normal clearance by the proteasome and lysosome. Phosphorylation of Htt regulates additional post-translational modifications, including Htt ubiquitination, SUMOylation, and acetylation, and increases Htt nuclear localization, cleavage, and clearance mediated by lysosomal-associated membrane protein 2A and Hsc70. We propose that IKK activates mutant Htt clearance until an age-related loss of proteasome/lysosome function promotes accumulation of toxic post-translationally modified mutant Htt. Thus, IKK activation may modulate mutant Htt neurotoxicity depending on the cell's ability to degrade the modified species.
U2 - 10.1083/jcb.200909067
DO - 10.1083/jcb.200909067
M3 - Article
VL - 187
SP - 1083
EP - 1099
JO - Journal of Cell Biology
JF - Journal of Cell Biology
IS - 7
ER -